AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,925 Cr | ₹2,435 Cr | ₹2,387 Cr | ₹5,016 Cr | ₹3,329 Cr |
What is the latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹3,925 Cr |
| Mar2024 | ₹2,435 Cr |
| Mar2023 | ₹2,387 Cr |
| Mar2022 | ₹5,016 Cr |
| Mar2021 | ₹3,329 Cr |
How is Cash Flow from Operating Activities of AUROBINDO PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,925 Cr | 61.21 | |
| Mar2024 | ₹2,435 Cr | 2.00 | |
| Mar2023 | ₹2,387 Cr | -52.42 | |
| Mar2022 | ₹5,016 Cr | 50.69 | |
| Mar2021 | ₹3,329 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹77,949.2 Cr | 1.9% | 7.4% | 8.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 1.9% |
7.4% |
8.6% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses